TS
PRAH

Thomas Steyer’s PRA Health Sciences, Inc. PRAH Stock Holding History

Thomas Steyer’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-350,000
Closed -$53.7M – 386
2021
Q1 		$53.7M Buy
+350,000
New +$47.5M 0.27% 69

Other funds holding PRAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Thomas Steyer's PRAH Position: Q2 2021 in Review

Thomas Steyer sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 350,000 shares — an estimated $53.7M sold.

Thomas Steyer first reported a position in PRAH in Q1 2021 and held it in 1 quarter. The position peaked at $53.7M in Q1 2021. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Thomas Steyer reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Thomas Steyer sold 350,000 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $53.7M.
  • Thomas Steyer first reported a position in PRA Health Sciences, Inc. in Q1 2021 and held it in 1 quarter.
  • Thomas Steyer's PRA Health Sciences, Inc. position peaked at $53.7M in Q1 2021.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.